Morgans says the Pilbara Minerals share price can rise 40%

This lithium share could be a bargain buy right now according to one leading broker.

| More on:
A young woman holds her hand to her mouth in surprise as she reads something on her laptop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been an uncharacteristically difficult period for the Pilbara Minerals Ltd (ASX: PLS) share price.

Concerns over falling lithium prices have put a lot of pressure on this mining giant's shares and has led to them losing approximately 21% of the value over the last six months.

Is the Pilbara Minerals share price weakness a buying opportunity?

One leading broker that believes investors should be snapping up this lithium share after recent weakness is Morgans.

According to a recent note, the broker has put an add rating and $5.30 price target on its shares.

Based on the latest Pilbara Minerals share price of $3.80, this implies potential upside of just under 40% for investors over the next 12 months.

What did the broker say?

Pilbara Minerals has become the broker's top pick in the industry recently thanks partly to its takeover appeal.

Morgans believes it could be an attractive option for a large miner that wants immediate exposure to lithium spodumene. It explained:

We see both AKE and PLS as potential targets in addition to the ongoing interest in LTR. The relative attractiveness of each depends on the needs of the buyer. AKE is cheaply priced on an EV / resource basis but has comparatively less spodumene. Spodumene is the most direct path to producing lithium hydroxide, the preferred form for the higher nickel content cathodes, which power the longer range vehicles preferred in western markets.

PLS is an Australian spodumene pure play and would suit an acquirer that is looking for a fast way to get exposure to lithium. PLS does not have the resource base of AKE though and is more expensive per tonne of LCE. The Gwanyang plant (PLS holds a minority share in JV with POSCO) is contracted to take 315ktpa of spodumene but the P1000 expansion will leave the company with a significant amount of yet to be contracted production. The company's size would restrict interest to larger mining houses, international chemicals companies, battery producers or OEMs.

All in all, don't be surprised if Liontown Resources Ltd (ASX: LTR) isn't the only lithium share to receive a takeover approach this year.

Motley Fool contributor James Mickleboro has positions in Allkem. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

Leading broker tips 50%+ upside for IDP Education shares

The team at Macquarie thinks this beaten down stock could be a buy.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Broker Notes

Bell Potter names the best ASX 200 stocks to buy in June

The broker is feeling bullish on these names this month. Let's find out why.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Bell Potter says this ASX 200 share can rise 25%

Let's see what the broker is saying about this stock.

Read more »

Stethoscope with a piggy bank in the middle.
Broker Notes

Australian health insurance: Does Macquarie prefer Medibank or NIB shares?

Medibank and NIB shares have both surged in 2025. Here’s what Macquarie expects now.

Read more »

Man smiling at a laptop because of a rising share price.
Broker Notes

9 ASX 200 shares just upgraded to strong buy ratings

Brokers have upgraded these shares amid expectations of price growth over the next 12 months.

Read more »

Red sell button on an Apple keyboard.
Broker Notes

Sell alert! Brokers say pull the plug on these 3 ASX 200 shares

Experts say it's time to press the sell button on these ASX 200 shares. Find out why.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Broker Notes

Macquarie forecasts 40% upside for this ASX All Ords stock

Let's see which stock the broker is tipping as a buy.

Read more »